Public information shows that this is Opicapone capsule, a new drug introduced by Fosun Pharma for the treatment of primary Parkinson's disease, which is a next-generation catechol oxygen methyltransferase inhibitor (COMT). Public information shows that opicapone is a new generation of peripheral cate...
Drug Insight: new drugs in development for Parkinson's disease For many years, levodopa has given most patients with Parkinson's disease excellent symptomatic benefit. This agent does not slow down the progression of t... C Colosimo,G Fabbrini,A Berardelli - 《Nat Clin Pract Neurol》 被引...
Ok! Credit: Pixabay/CC0 Public Domain Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a large phase 2 clinical trialpublish...
which is available as a continuous, subcutaneous infusion treatment for people with advanced Parkinson’s and motor symptoms that cannot be well controlled with oral medications.The drug was shown to reduce the amount of “off” time when motor problems and other symptoms...
An experimental drug targeting a genetic variant linked to Parkinson's disease had no effect on patients, according to the results of a new clinical trial published in The Lancet Neurology.
Inflammatory bowel disease raises the risk for Parkinson's disease, but anti-TNF therapy may reduce the risk, researchers report.
To determine the frequency of new-onset compulsive gambling or hypersexuality among regional patients with Parkinson disease (PD), ascertaining the relationship of these behaviors to PD drug use.PATIENTS AND METHODSWe retrospectively reviewed the medical records of patients from 7 rural southeastern Minne...
Results from early studies in mouse models of Parkinson’s disease have shown improvements in motor, cognitive and mood-related tasks in mice orally supplemented in this way.(p58) Ex vivo autologous stem cell gene therapy, in which a patient’s own stem cells are harvested, cultured, re-...
Neurodegenerative disorders such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS) are currently incurable pathologies with huge social and economic impacts closely related to the increasing of life expectancy in modern times. Al...
There is limited efficacy information with medications used for the treatment of Parkinson’s disease, for the improvement or resolution of parkinsonism symptoms following CARVYKTI® treatment. Guillain-Barré Syndrome: A fatal outcome...